Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

The Current Status of Percutaneous Coronary Intervention in Korea -Based on Year 2014 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) Registry-

  • Jang, Jae-Sik (Division of Cardiology, Busan Paik Hospital, University of Inje College of Medicine) ;
  • Han, Kyoo-Rok (Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University Medical Center) ;
  • Moon, Keon-Woong (Division of Cardiology, St. Vincent's Hospital, The Catholic University of Korea) ;
  • Jeon, Dong Woon (Division of Cardiology, National Health Insurance Service Ilsan Hospital) ;
  • Shin, Dong-Ho (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) ;
  • Kim, Jung-Sun (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) ;
  • Park, Duk-Woo (Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kang, Hyun-Jae (Department of Internal Medicine, Seoul National University Hospital) ;
  • Kim, Juhan (Division of Cardiology, Heart Center of Chonnam National University Hospital) ;
  • Bae, Jang-Whan (Department of Internal Medicine, Chungbuk National University College of Medicine) ;
  • Hur, Seung-Ho (Division of Cardiology, Keimyung University Dongsan Medical Center) ;
  • Kim, Byung Ok (Division of Cardiology, Sanggye-Paik Hospital, University of Inje College of Medicine) ;
  • Choi, Donghoon (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) ;
  • Gwon, Hyeon-Cheol (Heart Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Hyo-Soo (Department of Internal Medicine, Seoul National University Hospital)
  • Received : 2017.03.31
  • Accepted : 2017.04.18
  • Published : 2017.05.31
⟨ Previous Next ⟩

Abstract

Background and Objectives: Although several multicenter registries have evaluated percutaneous coronary intervention (PCI) procedures in Korea, those databases have been limited by non-standardized data collection and lack of uniform reporting methods. We aimed to collect and report data from a standardized database to analyze PCI procedures throughout the country. Materials and Methods: Both clinical and procedural data, as well as clinical outcomes data during hospital stay, were collected based on case report forms that used a standard set of 54 data elements. This report is based on 2014 Korean PCI registry cohort data. Results: A total of 92 hospitals offered data on 44967 PCI procedures. The median age was 66.0 interquartile range 57.0-74.0 years, and 70.3% were men. Thirty-eight percent of patients presented with acute myocardial infarction and one-third of all PCI procedures were performed in an urgent or emergency setting. Non-invasive stress tests were performed in 13.9% of cases, while coronary computed tomography angiography was used in 13.7% of cases prior to PCI. Radial artery access was used in 56.1% of all PCI procedures. Devices that used PCI included drug-eluting stent, plain old balloon angioplasty, drug-eluting balloon, and bare-metal stent (around 91%, 19%, 6%, and 1% of all procedures, respectively). The incidences of in-hospital death, non-fatal myocardial infarction, and stroke were 2.3%, 1.6%, and 0.2%, respectively. Conclusion: These data may provide an overview of the current PCI practices and in-hospital outcomes in Korea and could be used as a foundation for developing treatment guidelines and nationwide clinical research.

Keywords

References

  1. Grech ED. ABC of interventional cardiology: percutaneous coronary intervention. I: history and development. BMJ 2003;326:1080-2. https://doi.org/10.1136/bmj.326.7398.1080
  2. Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;130:2354-94. https://doi.org/10.1161/CIR.0000000000000133
  3. Authors/Task Force members, Windecker S, Kolh P, et al. 2014 ESC/ EACTS Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014;35:2541-619. https://doi.org/10.1093/eurheartj/ehu278
  4. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011;124:e574-651.
  5. O'Gara P, Kushner F, Ascheim D, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2013;61:e78-140.
  6. Bashore TM, Balter S, Barac A, et al. 2012 American College of Cardiology Foundation/Society for Cardiovascular Angiography and Interventions expert consensus document on cardiac catheterization laboratory standards update: A report of the American College of Cardiology Foundation Task Force on Expert Consensus documents developed in collaboration with the Society of Thoracic Surgeons and Society for Vascular Medicine. J Am Coll Cardiol 2012;59:2221-305. https://doi.org/10.1016/j.jacc.2012.02.010
  7. Krumholz HM, Anderson JL, Bachelder BL, et al. ACC/AHA 2008 performance measures for adults with ST-elevation and non-STelevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to develop performance measures for ST-elevation and non-ST-elevation myocardial infarction): developed in collaboration with the American Academy of Family Physicians and the American College of Emergency Physicians: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine. Circulation 2008;118:2596-648. https://doi.org/10.1161/CIRCULATIONAHA.108.191099
  8. Nallamothu BK, Tommaso CL, Anderson HV, et al. ACC/AHA/SCAI/ AMA-convened PCPI/NCQA 2013 performance measures for adults undergoing percutaneous coronary intervention: a report of the American college of cardiology/American heart association task force on performance measures, the society for cardiovascular angiography and interventions, the American medical associationconvened physician consortium for performance improvement, and the national committee for quality assurance. Circulation 2014;129:926-49. https://doi.org/10.1161/01.cir.0000441966.31451.3f
  9. Sim DS, Jeong MH, Kang JC. Current management of acute myocardial infarction: experience from the Korea acute myocardial infarction registry. J Cardiol 2010;56:1-7. https://doi.org/10.1016/j.jjcc.2010.04.002
  10. Hahn JY, Chun WJ, Kim JH, et al. Predictors and outcomes of side branch occlusion after main vessel stenting in coronary bifurcation lesions: results from the COBIS II Registry (COronary BIfurcation Stenting). J Am Coll Cardiol 2013;62:1654-9. https://doi.org/10.1016/j.jacc.2013.07.041
  11. Lee PH, Lee SW, Park HS, et al. Successful recanalization of native coronary chronic total occlusion is not associated with improved long-term survival. JACC Cardiovasc Interv 2016;9:530-8. https://doi.org/10.1016/j.jcin.2015.11.016
  12. Lee SH, Jeong MH, Han KR, et al. comparison of transradial and transfemoral approaches for percutaneous coronary intervention in patients with acute coronary syndrome and anemia. Am J Cardiol 2016;117:1582-7. https://doi.org/10.1016/j.amjcard.2016.02.030
  13. Kim KH, Kim CH, Jeong MH, et al. Differential benefit of statin in secondary prevention of acute myocardial infarction according to the level of triglyceride and high density lipoprotein cholesterol. Korean Circ J 2016;46:324-34. https://doi.org/10.4070/kcj.2016.46.3.324
  14. Dehmer GJ, Weaver D, Roe MT, et al. A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: a report from the CathPCI registry of the national cardiovascular data registry, 2010 through June 2011. J Am Coll Cardiol 2012;60:2017-31. https://doi.org/10.1016/j.jacc.2012.08.966
  15. Anderson HV, Shaw RE, Brindis RG, et al. A contemporary overview of percutaneous coronary interventions. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). J Am Coll Cardiol 2002;39:1096-103. https://doi.org/10.1016/S0735-1097(02)01733-3
  16. Banning AP, Baumbach A, Blackman D, et al. Percutaneous coronary intervention in the UK: recommendations for good practice 2015. Heart 2015;10(Suppl 3):1-13.
  17. Garcia del Blanco B, Hernandez Hernandez F, Rumoroso Cuevas JR, Trillo Nouche R. Spanish cardiac catheterization and coronary intervention registry. 23rd official report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990-2013). Rev Esp Cardiol (Engl Ed) 2014;67:1013-23. https://doi.org/10.1016/j.recesp.2014.08.005
  18. Harnek J, Nilsson J, Friberg O, et al. The 2011 outcome from the Swedish Health Care Registry on Heart Disease (SWEDEHEART). Scand Cardiovasc J 2013;47(Suppl 62):1-10.
  19. Jernberg T, Attebring MF, Hambraeus K, et al. The Swedish websystem for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART). Heart 2010;96:1617-21. https://doi.org/10.1136/hrt.2010.198804
  20. Zeymer U, Zahn R, Hochadel M, et al. Incications and complications of invasive diagnostic procedures and percutaneous coronary interventions in the year 2003. Results of the quality control registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Z Kardiol 2005;94:392-8. https://doi.org/10.1007/s00392-005-0233-2
  21. Bangalore S, Gupta N, Guo Y, Feit F. Trend in the use of drug eluting stents in the United States: insight from over 8.1 million coronary interventions. Int J Cardiol 2014;175:108-19. https://doi.org/10.1016/j.ijcard.2014.04.269
  22. Kalesan B, Pilgrim T, Heinimann K, et al. Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction. Eur Heart J 2012;33:977-87. https://doi.org/10.1093/eurheartj/ehs036
  23. Dattilo PB, Prasad A, Honeycutt E, Wang TY, Messenger JC. Contemporary patterns of fractional flow reserve and intravascular ultrasound use among patients undergoing percutaneous coronary intervention in the United States: insights from the National Cardiovascular Data Registry. J Am Coll Cardiol 2012;60:2337-9. https://doi.org/10.1016/j.jacc.2012.08.990
  24. Pothineni NV, Shah NS, Rochlani Y, et al. U.S. Trends in Inpatient Utilization of Fractional Flow Reserve and Percutaneous Coronary Intervention. J Am Coll Cardiol 2016;67:732-3.
  25. Peterson ED, Dai D, DeLong ER, et al. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coll Cardiol 2010;55:1923-32. https://doi.org/10.1016/j.jacc.2010.02.005
  26. Yan BP, Clark DJ, Buxton B, et al. Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries. Heart Lung Circ 2009;18:184-90. https://doi.org/10.1016/j.hlc.2008.10.005
  27. Committee for the Korean Guidelines for the Management of Dyslipidemia. 2015 Korean guidelines for the management of dyslipidemia: executive summary (English translation). Korean Circ J 2016;46:275-306. https://doi.org/10.4070/kcj.2016.46.3.275
  28. De Bruyne B, Pijls NH, Kalesan B, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 2012;367:991-1001. https://doi.org/10.1056/NEJMoa1205361
  29. Jang JS, Song YJ, Kang W, et al. Intravascular ultrasound-guided implantation of drug-eluting stents to improve outcome: a metaanalysis. JACC Cardiovasc Interv 2014;7:233-43.
  30. Hong SJ, Kim BK, Shin DH, et al. Effect of intravascular ultrasoundguided vs angiography-guided everolimus-eluting stent implantation: the ivus-xpl randomized clinical trial. JAMA 2015;314:2155-63. https://doi.org/10.1001/jama.2015.15454

Cited by

  1. Characteristics of national and major regional percutaneous coronary intervention registries: a structured literature review vol.14, pp.10, 2017, https://doi.org/10.4244/eij-d-18-00434
  2. Factors associated with the rates of coronary artery bypass graft and percutaneous coronary intervention vol.19, pp.1, 2017, https://doi.org/10.1186/s12872-019-1264-3
  3. 흉통환자의 관상동맥중재술 시행 여부에 따른 건강행위 및 건강지표 비교 - 간호정보조사지와 전자의무기록 분석- vol.19, pp.12, 2017, https://doi.org/10.5392/jkca.2019.19.12.279
  4. Long-Term Safety and Efficacy of Extended Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Real-World Practice vol.84, pp.12, 2017, https://doi.org/10.1253/circj.cj-20-0668
  5. Rajaie cardiovascular medical and research center-percutaneous coronary intervention registry: A real-world registry on coronary interventions in a tertiary teaching cardiovascular center vol.9, pp.2, 2020, https://doi.org/10.4103/rcm.rcm_11_20